| Healthcare and Medical Technology |
1 |
1 |
| Addiction |
0 |
0.47 |
| Alcoholism |
0 |
0.47 |
| Clinical Research |
0 |
0.45 |
| Meta-Analysis |
0 |
0.45 |
| Alzheimer Disease |
0 |
0.39 |
| Biologic Therapy |
0 |
0.34 |
| Blood |
0 |
0.3 |
| Grant |
0 |
0.3 |
| HIV Infection |
0 |
0.29 |
| Alcohol Abuse |
0 |
0.21 |
| Renal Disease |
0 |
0.21 |
| Antibiotics |
0 |
0.2 |
| Cardiovascular Imaging |
0 |
0.2 |
| Gout |
0 |
0.2 |
| Multiple Sclerosis |
0 |
0.2 |
| Systemic Lupus Erythematosus |
0 |
0.2 |
| Type 2 Diabetes Mellitus |
0 |
0.2 |
| Abuse |
0 |
0.15 |
| Amyloid-Beta |
0 |
0.15 |
| Antibiotic Resistance |
0 |
0.15 |
| Biomarker |
0 |
0.15 |
| Board Certification |
0 |
0.15 |
| Canada |
0 |
0.15 |
| Cancer |
0 |
0.15 |
| Connecticut |
0 |
0.15 |
| Echocardiography |
0 |
0.15 |
| Epidemiology |
0 |
0.15 |
| Europe |
0 |
0.15 |
| Food and Drug Administration (FDA) |
0 |
0.15 |
| Health Policy |
0 |
0.15 |
| Kidney |
0 |
0.15 |
| Lupus |
0 |
0.15 |
| Medical Innovations |
0 |
0.15 |
| Monoclonal Antibody |
0 |
0.15 |
| Nonprofit Organizations |
0 |
0.15 |
| Politics |
0 |
0.15 |
| Quality of Life |
0 |
0.15 |